Search - tctmd.com

Displaying 741 - 760 of 970

Sort: Relevancy | Date

News Daily News

COURAGE at 15 Years: Still No Survival Advantage for PCI

L.A. McKeown

November 10, 2015

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Daily News

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

News Daily News

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Caitlin E. Cox

October 28, 2015

News Industry News

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

October 27, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

News Conference News TCT 2015

Despite Setbacks, Research Into Myocardial Salvage Continues

October 12, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Daily News

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

Yael L. Maxwell

September 18, 2015

News Daily News

RECLOSE-3：对氯吡格雷无反应者改用普拉格雷可降低PCI术后死亡率

Yael L. Maxwell

September 18, 2015

News Conference News ESC 2015

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Yael L. Maxwell

September 01, 2015

News Conference News ESC 2015

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Yael L. Maxwell

August 31, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

News Daily News

肌钙蛋白 T 水平高预示着 2 型糖尿病及稳定型心脏疾病患者结局不佳

Todd Neale

August 17, 2015

News Daily News

钙化评分为零“保证”了无症状患者 15 年死亡率

August 06, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Daily News

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

August 04, 2015

Advertisement

COURAGE at 15 Years: Still No Survival Advantage for PCI

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

Despite Setbacks, Research Into Myocardial Salvage Continues

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

RECLOSE-3：对氯吡格雷无反应者改用普拉格雷可降低PCI术后死亡率

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

肌钙蛋白 T 水平高预示着 2 型糖尿病及稳定型心脏疾病患者结局不佳

钙化评分为零“保证”了无症状患者 15 年死亡率

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content